documents: FDA-2012-N-0284-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-N-0284-0007 FDA FDA-2012-N-0284 FDA CDER Memorandum December 5 2012 re for use of Sodium Nitroprusside to Reduce Blood Pressure in Pediatric Patients Other Memorandum 2012-12-05T05:00:00Z 2012 12 2012-12-05T05:00:00Z   2013-12-24T14:07:35Z   0 0 090000648117fc9d

Links from other tables